Edwards Lifesciences Corp (NYSE: EW) last traded at $85.21, up 1.15% on the session. The quote above updates while this page is open; the figures below are drawn from Edwards Lifesciences Corp’s own filings and are restated only when a new one is published.
Edwards Lifesciences Corp trades on NYSE under the ticker EW. Its market capitalisation is $49.12 billion.
Valuation measures for Edwards Lifesciences Corp, derived from the latest quote and its most recent SEC filing.
| Market cap | $49.12B |
|---|---|
| Enterprise value | $49.35B |
| P/E ratio | 48.97 |
| Price / sales | 7.54 |
| Price / book | 4.63 |
| Beta | 0.57 |
Trailing-twelve-month figures tagged in Edwards Lifesciences Corp's XBRL filings with the SEC.
| Revenue (TTM) | $6.51B |
|---|---|
| Net income (TTM) | $1.01B |
| EPS (TTM) | $1.74 |
| Gross margin | 77.84% |
| Operating margin | 22.25% |
| Return on equity | 9.48% |
| Cash | $2.91B |
Range and volume for EW over the past 52 weeks.
| 52-week high | $96.29 |
|---|---|
| 52-week low | $72.30 |
| Volume | 3.89M |
| Average volume | 3.84M |
| Previous close | $84.24 |
Invest a chosen dollar amount in Edwards Lifesciences Corp with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell EW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.